mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
0.08 |
0.02 |
mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.077 |
0.02 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.02 |
mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
0.075 |
0.03 |
mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
0.077 |
0.03 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.03 |
mRNA |
Bryostatin 1 |
GDSC1000 |
pan-cancer |
AAC |
-0.078 |
0.03 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.03 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.03 |
mRNA |
XAV-939 |
GDSC1000 |
pan-cancer |
AAC |
-0.075 |
0.03 |